avkАрхивъ внутренней медициныThe Russian Archives of Internal Medicine2226-67042411-6564“SINAPS” LLC10.20514/2226-6704-2023-13-5-335-343avk-1664Research ArticleОБЗОРНЫЕ СТАТЬИREVIEW ARTICLESИзменение показателей системы крови человека у больных COVID-19Changes in the Human Blood System in Patients with COVID-19https://orcid.org/0000-0003-2627-0626СафуановаГ. Ш.SafuanovaG. Sh.

Гузяль Шагбановна Сафуанова

кафедра терапии и общей врачебной практики с курсом гериатрии ИДПО

Уфа

Guzyal Sh. Safuanova

Department of Therapy and General Medical Practice with a Course of Geriatrics

Ufa

safuanova@bk.ruhttps://orcid.org/0000-0003-2617-9347КонстантиноваА. С.KonstantinovaA. S.

Уфа

Ufa

https://orcid.org/0000-0003-9936-3890РябчиковаН. Р.RyabchikovaN. R.

кафедра терапии и общей врачебной практики с курсом гериатрии ИДПО

Уфа

Department of Therapy and General Medical Practice with a Course of Geriatrics

Ufa

https://orcid.org/0000-0001-7944-8585СафуановаД. Р.SafuanovaD. R.

Москва

Moscow

Федеральное государственное бюджетное образовательное учреждение высшего образования «Башкирский государственный медицинский университет» Министерства здравоохранения Российской ФедерацииРоссияFederal State Budgetary Educational Institution of Higher Education «Bashkir State Medical University» of the Ministry of Healthcare of the Russian FederationRussian FederationГосударственное бюджетное учреждение здравоохранения «Республиканская клиническая больница им. Г. Г. Куватова» Министерства здравоохранения Республики БашкортостанРоссияState Budgetary Healthcare Institution «Kuvatov Republican Clinical Hospital» of the Ufa Healthcare DepartmentRussian FederationФедеральное государственное бюджетное учреждение «Национальный медицинский исследовательский центр Гематологии» Министерства здравоохранения Российской ФедерацииРоссияFederal State Budgetary Institution “National Medical Research Center of Hematology” of the Ministry of Health of the Russian FederationRussian Federation202322102023135335343Copyright © Сафуанова Г.Ш., Константинова А.С., Рябчикова Н.Р., Сафуанова Д.Р., 20232023Сафуанова Г.Ш., Константинова А.С., Рябчикова Н.Р., Сафуанова Д.Р.Safuanova G.S., Konstantinova A.S., Ryabchikova N.R., Safuanova D.R.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.medarhive.ru/jour/article/view/1664

   Как известно, вирус SARS-CoV-2 влияет практически на все системы, органы и ткани человека, вызывая их поражение в большей или меньшей степени. Наблюдение за пациентами, перенесшими COVID-19, во всем мире указывает на значительные изменения, происходящие в системе кроветворения и морфологии клеток крови. Настоящий обзор посвящен анализу литературных данных о влиянии вируса SARS-CoV-2 на изменения показателей системы крови человека, что имеет важное значение в практической работе всех специалистов здравоохранения.

   As is known, the SARS-CoV-2 virus affects almost all human systems, organs and tissues, causing their damage to a greater or lesser extent. Follow-up of COVID-19 patients worldwide.indicates significant changes occurring in the hematopoiesis system and morphology of blood cells. This review is devoted to the analysis of literature data on the effect of the SARS-CoV-2 virus on changes in the indicators of the human blood system, which is important in the practical work of all healthcare professionals.

COVID-19коронавирусная инфекцияанемиятромбоцитопениякоагулопатияCOVID-19coronavirus infectionanemiacytopeniathrombocytopeniacoagulopathyАвторы заявляют об отсутствии финансирования при проведении исследованияThe authors claim that there is no funding for the studyReferencesWenzhong L., Hualan L. COVID-19: Attacks the 1-Beta Chain of Hemoglobin and Captures the Porphyrin to Inhibit Human Heme Metabolism. Biological and Medicinal Chemistry. 2020 Mar; v5:38 Preprint. doi.:10.26434/chemrxiv. 11938173.Wenzhong L., Hualan L. COVID-19: Attacks the 1-Beta Chain of Hemoglobin and Captures the Porphyrin to Inhibit Human Heme Metabolism. Biological and Medicinal Chemistry. 2020 Mar; v5:38 Preprint. doi.:10.26434/chemrxiv. 11938173.Ehsani S. COVID-19 and iron dysregulation: distant sequence similarity between hepcidin and the novel coronavirus spike glycoprotein. Biology Direct. 2020;15 (19):1-13. Doi:10.1186/s13062-020-00275-2Ehsani S. COVID-19 and iron dysregulation: distant sequence similarity between hepcidin and the novel coronavirus spike glycoprotein. Biology Direct. 2020;15 (19):1-13. Doi:10.1186/s13062-020-00275-2Hirschhorn T, Stockwell BR. The development of the concept of ferroptosis. Free Radic Biol Med 2019 Mar; 133: 130-143. doi: 10.1016/j.freeradbiomed.2018.09.043.Hirschhorn T, Stockwell BR. The development of the concept of ferroptosis. Free Radic Biol Med 2019 Mar; 133: 130-143. doi: 10.1016/j.freeradbiomed.2018.09.043.Евтюгина Н.Г., Санникова С.С., Пешкова А.Д. и др. Количественные и качественные изменения клеток крови при COVID-19. Казанский мед. ж. 2021; 102 (2): 141–155. DOI: 10.17816/KMJ2021-141.Yevtyugina N.G., Sannikova S.S., Peshkova A.D., et al. Quantitative and qualitative changes of blood cells in COV ID-19. Kazan medical journal. 2021; 102 (2): 141-155. DOI: 10.17816/KMJ2021-141. [in Russian]Zhao J., Yang Y., Huang H. et al. Relationship between the ABO Blood Group and the COVID-19 Susceptibility. Clinical Infectious Diseases 2021;.73(2):328-331, doi: 10.1093/cid/ciaa1150Zhao J., Yang Y., Huang H. et al. Relationship between the ABO Blood Group and the COVID-19 Susceptibility. Clinical Infectious Diseases 2021;.73(2):328-331, doi: 10.1093/cid/ciaa1150Задумина Д.Н., Скворцов В.В. Изменение гематологических показателей при COVID-19. Лечащий Врач. 2022; 11(25): 30-36. DOI: 10.51793/OS.2022.25.11.005.Zadomina D.N., Skvortsov V.V. Change of hematological parameters in COVID-19. Lechaschi Vrach. 2022; 11 (25): 30-36. DOI: 10.51793/OS.2022.25.11.005. [in Russian]Liu Y, Sun W, Guo Y, et al. Association between platelet parameters and mortality in coronavirus disease 2019: Retrospective cohort study. Platelets. 2020 May 18; 31(4): 490-496. doi: 10.1080/09537104.2020.1754383.Liu Y, Sun W, Guo Y, et al. Association between platelet parameters and mortality in coronavirus disease 2019: Retrospective cohort study. Platelets. 2020 May 18; 31(4): 490-496. doi: 10.1080/09537104.2020.1754383.Zhang Y, Zeng X, Jiao Y, et al. Mechanisms involved in the development of thrombocytopenia in patients with COVID-19. Thromb Res. 2020 Sep; 193: 110-115. doi: 10.1016/j.thromres.2020.06.008.Zhang Y, Zeng X, Jiao Y, et al. Mechanisms involved in the development of thrombocytopenia in patients with COVID-19. Thromb Res. 2020 Sep; 193: 110-115. doi: 10.1016/j.thromres.2020.06.008.Guan WJ, Ni ZY, Hu Y, et al. China Medical Treatment Expert Group for Covid-19. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 2020 Apr 30; 382(18): 1708-1720. doi: 10.1056/NEJMoa2002032.Guan WJ, Ni ZY, Hu Y, et al. China Medical Treatment Expert Group for Covid-19. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 2020 Apr 30; 382(18): 1708-1720. doi: 10.1056/NEJMoa2002032.Yang X, Yang Q, Wang Y, et al. Thrombocytopenia and its association with mortality in patients with COVID-19. J ThrombHaemost. 2020 Jun; 18(6): 1469-1472. doi: 10.1111/jth.14848. Epub 2020 May 4. PMID: 32302435.Yang X, Yang Q, Wang Y, et al. Thrombocytopenia and its association with mortality in patients with COVID-19. J ThrombHaemost. 2020 Jun; 18(6): 1469-1472. doi: 10.1111/jth.14848. Epub 2020 May 4. PMID: 32302435.Levi M, Thachil J, Iba T, Levy JH. Coagulation abnormalities and thrombosis in patients with COVID-19. Lancet Haematol. 2020 Jun; 7(6): e438-e440. doi: 10.1016/S2352-3026(20)30145-9. Epub 2020 May 11. PMID: 32407672; PMCID: PMC7213964.Levi M, Thachil J, Iba T, Levy JH. Coagulation abnormalities and thrombosis in patients with COVID-19. Lancet Haematol. 2020 Jun; 7(6): e438-e440. doi: 10.1016/S2352-3026(20)30145-9. Epub 2020 May 11. PMID: 32407672; PMCID: PMC7213964.Thachil J. What do monitor platelet counts in COVID-19 teach us? J Thromb Haemost. 2020 Aug;18(8): 2071-2072. doi: 10.1111/jth.14879.Thachil J. What do monitor platelet counts in COVID-19 teach us? J Thromb Haemost. 2020 Aug;18(8): 2071-2072. doi: 10.1111/jth.14879.Lippi G, Plebani M, Henry BM. Thrombocytopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: A meta-analysis. ClinChimActa.2020 Jul; 506: 145-148. doi: 10.1016/j.cca.2020.03.022.Lippi G, Plebani M, Henry BM. Thrombocytopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: A meta-analysis. ClinChimActa.2020 Jul; 506: 145-148. doi: 10.1016/j.cca.2020.03.022.Henry BM, de Oliveira MHS, Benoit S, Plebani M, et al. Hematologic, biochemical and immune biomarker abnormalities associated with severe illness and mortality in coronavirus disease 2019 (COVID-19): a meta-analysis. Clin Chem Lab Med. 2020 Jun 25; 58(7): 1021-1028. doi: 10.1515/cclm-2020-0369.Henry BM, de Oliveira MHS, Benoit S, Plebani M, et al. Hematologic, biochemical and immune biomarker abnormalities associated with severe illness and mortality in coronavirus disease 2019 (COVID-19): a meta-analysis. Clin Chem Lab Med. 2020 Jun 25; 58(7): 1021-1028. doi: 10.1515/cclm-2020-0369.Bomhof G, Mutsaers PGNJ, Leebeek FWG, et al. COVID-19-associated immune thrombocytopenia. Br J Haematol. 2020 Jul; 190(2): e61-e64. doi: 10.1111/bjh.16850.Bomhof G, Mutsaers PGNJ, Leebeek FWG, et al. COVID-19-associated immune thrombocytopenia. Br J Haematol. 2020 Jul; 190(2): e61-e64. doi: 10.1111/bjh.16850.Chabert A, Hamzeh-Cognasse H, Pozzetto B, et al. Human platelets and their capacity of binding viruses: meaning and challenges? BMC Immunol.2015 Apr 28; 16: 26. doi: 10.1186/s12865-015-0092-1.Chabert A, Hamzeh-Cognasse H, Pozzetto B, et al. Human platelets and their capacity of binding viruses: meaning and challenges? BMC Immunol.2015 Apr 28; 16: 26. doi: 10.1186/s12865-015-0092-1.Assinger A. Platelets and infection — an emerging role of platelets in viral infection.. Frontiers in immunology. 2014, Dec 18; vol. 5: 649. doi: 10.3389/fimmu.2014.00649Assinger A. Platelets and infection — an emerging role of platelets in viral infection.. Frontiers in immunology. 2014, Dec 18; vol. 5: 649. doi: 10.3389/fimmu.2014.00649Seyoum M, Enawgaw B, Melku M. Human blood platelets and viruses: defense mechanism and role in the removal of viral pathogens. Thromb J. 2018 Jul 17; 16: 16. doi: 10.1186/s12959-018-0170-8.Seyoum M, Enawgaw B, Melku M. Human blood platelets and viruses: defense mechanism and role in the removal of viral pathogens. Thromb J. 2018 Jul 17; 16: 16. doi: 10.1186/s12959-018-0170-8.Lador A, Leshem-Lev D, Spectre G, et al. Characterization of surface antigens of reticulated immature platelets. J Thromb Thrombolysis. 2017 Oct; 44(3): 291-297. doi: 10.1007/s11239-017-1533-x.Lador A, Leshem-Lev D, Spectre G, et al. Characterization of surface antigens of reticulated immature platelets. J Thromb Thrombolysis. 2017 Oct; 44(3): 291-297. doi: 10.1007/s11239-017-1533-x.Handtke S, Steil L, Palankar R, et al. Role of Platelet Size Revisited-Function and Protein Composition of Large and Small Platelets. ThrombHaemost. 2019 Mar; 119(3): 407-420. doi: 10.1055/s-0039-1677875.Handtke S, Steil L, Palankar R, et al. Role of Platelet Size Revisited-Function and Protein Composition of Large and Small Platelets. ThrombHaemost. 2019 Mar; 119(3): 407-420. doi: 10.1055/s-0039-1677875.Hille L, Lenz M, Vlachos A, et al. Ultrastructural, transcriptional, and functional differences between human reticulated and non-reticulated platelets. J ThrombHaemost. 2020 Aug; 18(8): 2034-2046. doi: 10.1111/jth.14895.Hille L, Lenz M, Vlachos A, et al. Ultrastructural, transcriptional, and functional differences between human reticulated and non-reticulated platelets. J ThrombHaemost. 2020 Aug; 18(8): 2034-2046. doi: 10.1111/jth.14895.Handtke S, Thiele T. Large and small platelets-(When) do they differ? J ThrombHaemost. 2020 Jun; 18(6): 1256-1267. doi: 10.1111/jth.14788.Handtke S, Thiele T. Large and small platelets-(When) do they differ? J ThrombHaemost. 2020 Jun; 18(6): 1256-1267. doi: 10.1111/jth.14788.Zhang S, Liu Y, Wang X, et al. SARS-CoV-2 binds platelet ACE2 to enhance thrombosis in COVID-19. J HematolOncol. 2020 Sep 4; 13(1): 120. doi: 10.1186/s13045-020-00954-7.Zhang S, Liu Y, Wang X, et al. SARS-CoV-2 binds platelet ACE2 to enhance thrombosis in COVID-19. J HematolOncol. 2020 Sep 4; 13(1): 120. doi: 10.1186/s13045-020-00954-7.Hottz ED, Azevedo-Quintanilha IG, Palhinha L, et al. Platelet activation and platelet-monocyte aggregate formation trigger tissue factor expression in patients with severe COVID-19. Blood. 2020 Sep 10; 136(11): 1330-1341. doi: 10.1182/blood.2020007252.Hottz ED, Azevedo-Quintanilha IG, Palhinha L, et al. Platelet activation and platelet-monocyte aggregate formation trigger tissue factor expression in patients with severe COVID-19. Blood. 2020 Sep 10; 136(11): 1330-1341. doi: 10.1182/blood.2020007252.Manne BK, Denorme F, Middleton EA, et al. Platelet gene expression and function in patients with COVID-19. Blood. 2020 Sep 10; 136(11): 1317-1329. doi: 10.1182/blood.2020007214.Manne BK, Denorme F, Middleton EA, et al. Platelet gene expression and function in patients with COVID-19. Blood. 2020 Sep 10; 136(11): 1317-1329. doi: 10.1182/blood.2020007214.Connors JM, Levy JH. COVID-19 and its implications for thrombosis and anticoagulation.Blood. 2020 Jun 4; 135(23): 2033-2040. doi: 10.1182/blood.2020006000.Connors JM, Levy JH. COVID-19 and its implications for thrombosis and anticoagulation.Blood. 2020 Jun 4; 135(23): 2033-2040. doi: 10.1182/blood.2020006000.Spyropoulos AC, Levy JH, Ageno W, et al; Subcommittee on Perioperative, Critical Care Thrombosis, Haemostasis of the Scientific, Standardization Committee of the International Society on Thrombosis and Haemostasis. Scientific and Standardization Committee communication: Clinical guidance on the diagnosis, prevention, and treatment of venous thromboembolism in hospitalized patients with COVID-19. J ThrombHaemost. 2020 Aug; 18(8): 1859-1865. doi: 10.1111/jth.14929.Spyropoulos AC, Levy JH, Ageno W, et al; Subcommittee on Perioperative, Critical Care Thrombosis, Haemostasis of the Scientific, Standardization Committee of the International Society on Thrombosis and Haemostasis. Scientific and Standardization Committee communication: Clinical guidance on the diagnosis, prevention, and treatment of venous thromboembolism in hospitalized patients with COVID-19. J ThrombHaemost. 2020 Aug; 18(8): 1859-1865. doi: 10.1111/jth.14929.Helms J, Tacquard C, Severac F, et al; CRICS TRIGGERSEP Group (Clinical Research in Intensive Care and Sepsis Trial Group for Global Evaluation and Research in Sepsis). High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study. Intensive Care Med. 2020 Jun; 46(6): 1089-1098. doi: 10.1007/s00134-020-06062-x.Helms J, Tacquard C, Severac F, et al; CRICS TRIGGERSEP Group (Clinical Research in Intensive Care and Sepsis Trial Group for Global Evaluation and Research in Sepsis). High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study. Intensive Care Med. 2020 Jun; 46(6): 1089-1098. doi: 10.1007/s00134-020-06062-x.Han H, Yang L, Liu R, et al. Prominent changes in blood coagulation of patients with SARS-CoV-2 infection. Clin Chem Lab Med. 2020 Jun 25; 58(7): 1116-1120. doi: 10.1515/cclm-2020-0188.Han H, Yang L, Liu R, et al. Prominent changes in blood coagulation of patients with SARS-CoV-2 infection. Clin Chem Lab Med. 2020 Jun 25; 58(7): 1116-1120. doi: 10.1515/cclm-2020-0188.Li, Q., Cao, Y., Chen, L. et al. Hematological features of persons with COVID-19. Leukemia. 2020.34:2163–2172 doi:10.1038/s41375-020-0910-1Li, Q., Cao, Y., Chen, L. et al. Hematological features of persons with COVID-19. Leukemia. 2020.34:2163–2172 doi:10.1038/s41375-020-0910-1Thachil J, Cushman M, Srivastava A. A proposal for staging COVID-19 coagulopathy.Res PractThrombHaemost. 2020; 4(5): 731-736. Published 2020 Jul 6. doi: 10.1002/rth2.12372Thachil J, Cushman M, Srivastava A. A proposal for staging COVID-19 coagulopathy.Res PractThrombHaemost. 2020; 4(5): 731-736. Published 2020 Jul 6. doi: 10.1002/rth2.12372Escher R, Breakey N, Lämmle B. Severe COVID-19 infection associated with endothelial activation. Thromb Res. 2020 Jun; 190: 62. doi: 10.1016/j.thromres.2020.04.014.Escher R, Breakey N, Lämmle B. Severe COVID-19 infection associated with endothelial activation. Thromb Res. 2020 Jun; 190: 62. doi: 10.1016/j.thromres.2020.04.014.Othman M, Labelle A, Mazzetti I, et al. Adenovirus-induced thrombocytopenia: the role of von Willebrand factor and P-selectin in mediating accelerated platelet clearance. Blood. 2007 Apr 1; 109(7): 2832-9. doi: 10.1182/blood-2006-06-032524. PMID: 17148587.Othman M, Labelle A, Mazzetti I, et al. Adenovirus-induced thrombocytopenia: the role of von Willebrand factor and P-selectin in mediating accelerated platelet clearance. Blood. 2007 Apr 1; 109(7): 2832-9. doi: 10.1182/blood-2006-06-032524. PMID: 17148587.Escher R, Breakey N, Lämmle B. ADAMTS13 activity, von Willebrand factor, factor VIII and D-dimers in COVID-19 inpatients. Thromb Res. 2020 Aug; 192: 174-175. doi: 10.1016/j.thromres.2020.05.032.Escher R, Breakey N, Lämmle B. ADAMTS13 activity, von Willebrand factor, factor VIII and D-dimers in COVID-19 inpatients. Thromb Res. 2020 Aug; 192: 174-175. doi: 10.1016/j.thromres.2020.05.032.Martinelli N, Montagnana M, Pizzolo F, et al. A relative ADAMTS13 deficiency supports the presence of a secondary microangiopathy in COVID 19. Thromb Res. 2020 Sep; 193: 170-172. doi: 10.1016/j.thromres.2020.07.034.Martinelli N, Montagnana M, Pizzolo F, et al. A relative ADAMTS13 deficiency supports the presence of a secondary microangiopathy in COVID 19. Thromb Res. 2020 Sep; 193: 170-172. doi: 10.1016/j.thromres.2020.07.034.Blasi A, von Meijenfeldt FA, Adelmeijer J, et al. In vitro hypercoagulability and ongoing in vivo activation of coagulation and fibrinolysis in COVID-19 patients on anticoagulation. J ThrombHaemost. 2020 Oct; 18(10): 2646-2653. doi: 10.1111/jth.15043.Blasi A, von Meijenfeldt FA, Adelmeijer J, et al. In vitro hypercoagulability and ongoing in vivo activation of coagulation and fibrinolysis in COVID-19 patients on anticoagulation. J ThrombHaemost. 2020 Oct; 18(10): 2646-2653. doi: 10.1111/jth.15043.O. Otto, P. Rosendahl, et al., J. Guck Real-time deformability cytometry: on-the-fly cell mechanical phenotyping/ Nature Methods, 2015, 12: 199-202 doi: 10.1038/nmeth.3281.O. Otto, P. Rosendahl, et al., J. Guck Real-time deformability cytometry: on-the-fly cell mechanical phenotyping/ Nature Methods, 2015, 12: 199-202 doi: 10.1038/nmeth.3281.Kubánková M, Hohberger B, Hoffmanns J, et al. Physical phenotype of blood cells is altered in COVID-19. Biophys J. 2021 Jul 20; 120(14): 2838-2847. doi: 10.1016/j.bpj.2021.05.025.Kubánková M, Hohberger B, Hoffmanns J, et al. Physical phenotype of blood cells is altered in COVID-19. Biophys J. 2021 Jul 20; 120(14): 2838-2847. doi: 10.1016/j.bpj.2021.05.025.Kaur G, Sandeep F, Olayinka O, et al. Morphologic Changes in Circulating Blood Cells of COVID-19 Patients. Cureus. 2021 Feb 18; 13(2): 13416. doi: 10.7759/cureus.13416. PMID: 33758711; PMCID: PMC7978157Kaur G, Sandeep F, Olayinka O, et al. Morphologic Changes in Circulating Blood Cells of COVID-19 Patients. Cureus. 2021 Feb 18; 13(2): 13416. doi: 10.7759/cureus.13416. PMID: 33758711; PMCID: PMC7978157Багненко, С. Ф., Рассохин, В. В., Трофимова и др. Эволюция пандемии COVID-19. Балтийский медицинский образовательный центр. 2021. 410 с.Bagnenko, S.F., Rassokhin, V.V., Trofimova et al. Evolution of the COVID-19 pandemic. Baltic Medical Education Center. 2021: 410 р. [in Russian]Министерство здравоохранения Российской Федерации. Временные методические рекомендации: Профилактика, диагностика и лечение новой коронавирусной инфекции (COVID-19). 2022. Версия 16 : 249 с.Ministry of Health of the Russian Federation. Temporary methodological recommendations: Prevention, Diagnosis and Treatment of New Coronavirus Infection (COVID-19). 2022, Version 16 :249. [in Russian]Садретдинов М.А., Тимербулатов Ш.В., Валишин Д.А., и др. Диагностика COVID-19: неиспользованные технологии — возможности общего анализа крови. Медицинский вестник Башкортостана. 2020. Т. 15, № 3(87). С. 31-34.Sadretdinov M.A., Timerbulatov Sh.V., Valishin D.A., et al. COVID-19 diagnostics: Unused technologies — General blood analysis capabilities // Bashkortostan Medical Journal. 2020. vol. 15, 3(87): 31-34. [in Russian]Тимофеева Н.Ю., Кострова О.Ю., Стоменская И.С., и др. Изменения показателей общего анализа крови и коагулограммы при легком течении коронавирусной инфекции. Евразийский мед. журнал. 2021. № 2. С. 44-49.. DOI: 10.47026/2413-4864-2021-2-44-49.Timofeeva N.Yu., Kostrova O.Yu., Stomenskaya I.S., et al. Changes in the indicators of the general blood test and coagulogram in the mild course of coronavirus infection . Acta medica Eurasica. 2021. 2: 44-49. DOI: 10.47026/2413-4864-2021-2-44-49. [in Russian]Губенко Н.С., Будко А.А., Плисюк А.Г. и др. Связь показателей общего анализа крови с тяжестью течения COVID-19 у госпитализированных пациентов. Южно-Российский журнал терапевтической практики. 2021; 2(1): 90-101. doi.10.21886/2712-8156-2021-2-1-90-101.Gubenko N.S., Budko A.A., Plisyuk A.G. et al. The relationship of the indicators of the general blood test with the severity of COVID-19 in hospitalized patients. South-Russian Journal of Therapeutic Practice. 2021; 2(1): 90-101. doi. 10.21886/2712-8156-2021-2-1-90-101. [in Russian]

The authors declare that there are no conflicts of interest present.